Dose- and time-dependent antiplatelet effects of aspirin

Christina Perneby, N. Håkan Wallén, Cathy Rooney, +2

Thrombosis and Haemostasis

Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis

Opeyemi Stella Ademowo, Belinda Hernández, Emily S. Collins, +7

Annals of the Rheumatic Diseases

Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer

Keefe Murphy, Thomas Brendan Murphy, Susie Boyce, +16

Molecular Oncology

Development of a label‐free LC‐MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy

Brian Morrissey, C. O'Shea, John Armstrong, +5

PROTEOMICS - CLINICAL APPLICATIONS

Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Nina S. McCarthy, Ciara Vangjeli, Praveen Surendran, +14

Atherosclerosis

Multiplexed Measurement of Candidate Blood Protein Biomarkers of Heart Failure

Claire Tonry, Kenneth McDonald, Mark Ledwidge, +7

ESC Heart Failure